Military | Delta Airlines | Tesla investor. Trying to be on the right side of change to have a better future. wwe the only consist television program I watch
🚨 BREAKING: $HIMS SUPER BOWL AD HITS 93% SALES IMPACT SCORE
"'Rich People Live Longer' drove a major spike in purchasing likelihood, which we measure with consumers both before and after watching the ad. This helps us understand how effective the ad was at moving the needle."
Source: @zappi_io, a leading consumer insights platform
NEWS: Tesla now has 200 Model Y Robotaxis operating across Austin and the Bay Area.
Number of Model Ys:
• Bay Area: 158
• Austin: 42
This fleet of 200 vehicles is now generating an estimated $1.5 million to $2 million in revenue per month.
Cybercab production is scheduled to start in less than 103 days
Source: https://t.co/c6Gv6ZP5q9
$OSCR CEO: “Our stock should be between $45-$55 a share by the end of 2026.”
He said this last year, and assumptions were based on no ACA subsidy extension.
Now that we are getting a 3 year extension, there should be further upside.
$OSCR will mint millionaires…
Tesla's FSD counter hit 6.5B miles on November 22nd, 2025. It's at 7.18B as of this morning, 48 days later. If we add another ~700M miles every ~50 days, we would need another 150 days (5 months) to hit Elon's guesstimate of 10B miles on FSD required to unlock Unsupervised
From this perspective, no one else has even started the race toward generalized autonomy yet $TSLA
Top stocks for 2026 plan to buy a share of each stock when ever they drop 5% of more
Tesla
Pltr
Nvda
Celh
Vktx
App
Sezl
Nbis
Duol
Avgo
Zeta
Crwd
Tmdx
Vrt
$HIMS
🚨 ZAVA'S 2024 ANNUAL REPORT JUST DROPPED AND IT'S A BANGER
1. Revenue growth (+97%) from $25.9M to $51.0M
"A key driver of this growth was the success of our GLP1 weight loss business, along with a number of other optimisations for patient acquisition and retention."
2. For the first time in YEARS, Zava was profitable (+$4.5M)
A nearly $5M earnings swing after losing ~$400k in 2023
"Along with substantial revenue growth in 2024, we have seen a return to profitability, which will allow the Company to continue to fund growth initiatives and be successful in 2025."
3. Profitable in 2025 as well
"The company was profitable in 2024 and is profitable in 2025."
4. GLP-1s the primary growth engine
"A key driver of this growth was the success of our GLP1 weight loss business, along with a number of other optimisations for patient acquisition and retention."
5. $HIMS acquisition
"On 1st of July 2025 the Company's parent company, Zava Global GmbH, was acquired by H&H Germany GmbH, a company ultimately owned by Hims & Hers Health, Inc., and Hims & Hers Health, Inc. are now the ultimate controlling party of the Health Bridge Limited."
6. "Medication revenue" SKYROCKETED 16x in 2024, from $1.0M to $16.5M
Previously, most of Zava's revenue was from its "platform fee". Now 1/3 of revenue from medications (GLP-1s).
7. Balance sheet cleanup: $7.7M loan entirely paid off
"In 2025 the company repaid all external debt, achieving a net assets position, and is now in a position to sustain its own operations and growth."
Note: I converted all financial figures from GBP to USD. Conversion rate used: £1 = $1.27 (approximate GBP/USD rate as of December 2024)
Link below to the full report: